1007832

Frontida BioPharm Inc — FEI 2523348

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 31, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures